COVICI-SURV: COVID-19 Vaccination Around ICI Start and Survival

Clinical trial NCT07729241 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07729241
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Cancer Immune Checkpoint Inhibitors COVID-19 Vaccination Survival

Start date: 2020-12-28
Primary completion: 2024-12-31
Enrollment: 95015

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.